Evidence map›Paper›PMID 34698987›Full record

ArticleInternational journal of computer assisted radiology and surgery2022

An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [

Alexander P Seiffert, Adolfo Gómez-Grande, Gonzalo Castro-Leal, Antonia Rodríguez, David Palomino-Fernández, Enrique J Gómez, Patricia Sánchez-González, Héctor Bueno

Open access · hybridAbstract read
In one paragraph

Article in International journal of computer assisted radiology and surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Alexander P Seiffert *Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain. ap.seiffert@upm.es.ORCID http://orcid.org/0000-0001-7274-244X
Adolfo Gómez-Grande *Department of Nuclear Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain. adolfo.gomez@salud.madrid.org.ORCID http://orcid.org/0000-0002-7925-8826
Gonzalo Castro-LealBiomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0002-5496-971X
Antonia RodríguezDepartment of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
David Palomino-FernándezBiomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0002-4398-7795
Enrique J GómezBiomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0001-6998-1407
Patricia Sánchez-GonzálezBiomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0001-9871-0884
Héctor BuenoCardiology Department and Instituto de Investigación Sanitaria (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0003-0277-7596
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESHospital Universitario 12 De Octubre · ESUniversidad Politécnica de Madrid · ESEuropean Telecommunications Standards Institute · FRUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChemotherapy-induced cardiotoxicity is one of the main complications during and after cancer treatment. While echocardiography is the most used technique in clinical practice to evaluate left ventricular (LV) dysfunction, a multimodal approach is preferred for the early detection of anthracycline-induced cardiotoxicity. In this paper, an image processing tool allowing the qualitative and quantitative analysis of myocardial metabolic activity by [

methodsThe methodology is based on cardiac single photon emission computed tomography image processing protocols used in clinical practice. LV polar maps are created, and quantitative regional values are calculated. The tool was validated in a study group of 24 patients with Hodgkin or non-Hodgkin lymphoma (HL and NHL, respectively) treated with anthracyclines. Staging, interim and end-of-treatment [

resultsResults show an overall increase of metabolic activity in the interim PET image acquired while on treatment compared to staging PET, which then decreased in the end-of-treatment scan. Positive correlation coefficients between staging and interim scans, and negative correlation coefficients between interim and end-of-treatment scans also support this finding. Metabolic changes occur predominantly in the septal region.

conclusionThe proposed methodology and presented software solution provides the capability to assess quantitatively myocardial metabolism acquired by routine [

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyAnthracyclinesCardiotoxicityHumansMyocardiumPositron-Emission TomographyRadiopharmaceuticalsAnthracyclinesFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDG PET/CTCardiotoxicityComputer-aided diagnosisMyocardial metabolism quantification

Identifiers

PMID34698987
PMCPMC8784503
OpenAlexW3209896736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.